Of clinical relevance, higher expression levels of STAT3, AHR, and CCR2 modules (Figs 2, 3, and 6) are associated with shorter survival in GBM and LGG, and these modules also distinguish between molecular subclasses of GBM and LGG. This evidence concerns the gene CCR2 and glioblastoma.